Omicia has appointed Heidi Rehm, Geoffrey Ginsberg, Thomas Quertermous, and Mark Yandell to its scientific advisory board. Rehm is director of the Laboratory for Molecular Medicine at Partners Healthcare Personalized Medicine and associate professor of pathology at Harvard Medical School. Ginsberg is director of genomic medicine at the Duke Institute for Genome Sciences & Policy, executive director of Duke's Center for Personalized Medicine and Precision, and a professor of medicine and biomedical engineering. Quertermous is the William G. Irwin professor of medicine and director of research for the division of cardiovascular medicine at Stanford University. Yandell is co-director of the University of Utah's USTAR Center for Genetic Discovery, a professor of human genetics, and a co-inventor of Omicia's VAAST and Phevor algorithms.
The UK's National Health Service has appointed John Burn to its board of directors as a non-executive director for four years beginning July 1. Burn is the chief medical officer of QuantuMDx and holds the NHS Endowed Chair in Clinical Genetics at Newcastle University.